Adjuvant checkpoint inhibitor trials: Is disease-free survival an appropriate endpoint? Journal of cancer policy Khaki, A. R., Lythgoe, M. P., Prasad, V. 2023; 35: 100402

View details for DOI 10.1016/j.jcpo.2023.100402

View details for PubMedID 36639103